Cypress Funds’s Cognizant CTSH Stock Holding History

Cypress Funds’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-325,000	Closed	-$21.6M	–	21
2017 Q2	$21.6M	Buy	+325,000	New	+$20.6M	4.24%	14

Other funds holding CTSH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Cypress Funds's CTSH Position: Q3 2017 in Review

Cypress Funds sold out of Cognizant (CTSH) in Q3 2017, closing a stake of 325,000 shares — an estimated $21.6M sold.

Cypress Funds first reported a position in CTSH in Q2 2017 and held it in 1 quarter. The position peaked at $21.6M in Q2 2017. 915 funds tracked by Wall St. Rank hold CTSH as of Q3 2017.

Cypress Funds reported no remaining Cognizant position as of Q3 2017 after selling out during the quarter.
Cypress Funds sold 325,000 Cognizant shares in Q3 2017, an estimated $21.6M.
Cypress Funds first reported a position in Cognizant in Q2 2017 and held it in 1 quarter.
Cypress Funds's Cognizant position peaked at $21.6M in Q2 2017.
915 funds tracked by Wall St. Rank held Cognizant as of Q3 2017.

Based on Cypress Funds's 13F filing for Q3 2017, filed 7 Nov 2017.